Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00704 | DBA-DM4 | 905449-84-5 |
| DBA-DM4 is a drug-linker conjugate composed of a potent a tubulin inhibitor DM1 and a linker SPDP to make antibody drug conjugate (ADC). | Inquiry | |
| BADC-00724 | ALPHA-AMANITIN | 23109-05-9 |
| α-Amanitin is produced by the strain of Amanita phalloides. It is highly toxic to humans and can cause salivation, vomiting, bleeding, diarrhea, cyanosis, muscle convulsions, spasms, and death. It is the principal toxin of several deadly poisonous mushrooms and exerts its toxic effects by inhibiting RNA polymerase II. | Inquiry | |
| BADC-00725 | OSu-Glu-vc-PAB-MMAE | |
| OSu-Glu-vc-PAB-MMAE is a drug-linker conjugate for ADC by using monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via OSu-Glu-vc-PAB. | Inquiry | |
| BADC-00726 | OSu-PEG4-vc-PAB-DMEA-Duocarmycin SA | |
| OSu-PEG4-vc-PAB-DMEA-Duocarmycin SA is a drug-linker conjugate for ADC by using Duocarmycin SA (a potent antitumor antibiotic), linked via OSu-PEG4-vc-PAB-DMEA. | Inquiry | |
| BADC-00727 | Mylotarg-linker | |
| Mylotarg-linker is a drug-linker conjugate for ADC by using N-Acetyl-Calicheamicin and Osu-AcBut-acetyl hydrozide derivative. | Inquiry | |
| BADC-00728 | OSu-Glu-vc-PAB-MMAD | |
| OSu-Glu-vc-PAB-MMAD is a drug-linker conjugate for ADC by using Monomethyl Dolastatin 10 (MMAD, a potent tubulin inhibitor), linked via OSu-Glu-vc-PAB. | Inquiry | |
| BADC-00729 | OSu-PEG4-vc-PAB-DMEA-Duocarmycin TM | |
| OSu-PEG4-vc-PAB-DMEA-Duocarmycin TM is a drug-linker conjugate for ADC by using Duocarmycin TM (a potent antitumor antibiotic), linked via OSu-PEG4-vc-PAB-DMEA. | Inquiry | |
| BADC-00730 | OSu-PEG4-vc-PAB-DMEA-Duocarmycin DM | |
| OSu-PEG4-vc-PAB-DMEA-Duocarmycin DM is a drug-linker conjugate for ADC by using Duocarmycin DM (a potent antitumor antibiotic), linked via OSu-PEG4-vc-PAB-DMEA. | Inquiry | |
| BADC-00731 | MC-MMD-10 | |
| MC-MMD-10 is a drug-linker conjugate for ADC by using MMD-10 and the linker MC. | Inquiry | |
| BADC-00733 | MC-vc-PAB-C6-a-amanitin | |
| MC-vc-PAB-C6-a-amanitin is a drug-linker conjugate for ADC by using a-amanitin (a potent bicyclic octapeptide cytotoxin), linked via MC-vc-PAB-C6. | Inquiry | |
| BADC-00734 | MC-vc-PAB-DMEA-(PEG2)-duocarmycin SA | |
| MC-vc-PAB-DMEA-(PEG2)-duocarmycin SA is a drug-linker conjugate for ADC by using Duocarmycin SA (a potent antitumor antibiotic), linked via MC-vc-PAB-DMEA-(PEG2). | Inquiry | |
| BADC-00736 | MC-va-PAB-MMAD | |
| MC-va-PAB-MMAD is a drug-linker conjugate for ADC by using Monomethyl Dolastatin 10 (MMAD, a potent tubulin inhibitor), linked via MC-va-PAB. | Inquiry | |
| BADC-00737 | MA-PEG4-VC-PAB-DMEA-PNU159682 | 2259318-52-8 |
| MA-PEG4-VC-PAB-DMEA-PNU159682 is a drug-linker conjugate for ADC by using PNU159682 (a potent DNA topoisomerase II inhibitor), linked via MA-PEG4-VC-PAB-DMEA. | Inquiry | |
| BADC-00738 | MA-PEG4-VA-PBD | 1342820-68-1 |
| MA-PEG4-VA-PBD is a drug-linker conjugate for ADC by using PBD (Pyrrolobenzodiazepine dimers, a potent antitumor antibiotic), linked via MA-PEG4-VA. | Inquiry | |
| BADC-00739 | MC-vc-PAB-MMAD | |
| MC-vc-PAB-MMAD is a drug-linker conjugate for ADC by using Monomethyl Dolastatin 10 (MMAD, a potent tubulin inhibitor), linked via MC-vc-PAB. | Inquiry | |
| BADC-00740 | MC-vc-PAB-Auristatin 0101 | |
| MC-vc-PAB-Auristatin 0101 is a drug-linker conjugate for ADC by using Auristatin 0101 (an auristatin microtubule inhibitor), linked via MC-vc-PAB. | Inquiry | |
| BADC-00741 | MA-PEG8-VA-PAB-SG3199 | |
| MA-PEG8-VA-PAB-SG3199 is a drug-linker conjugate for ADC by using SG3199 (a PBD dimer,has a potently cytotoxic against cancer cell lines), linked via MA-PEG8-VA-PAB. | Inquiry | |
| BADC-00743 | MA-PEG4-vc-PAB-DMEA-duocarmycin TM | |
| MA-PEG4-vc-PAB-DMEA-duocarmycin TM is a drug-linker conjugate for ADC by using Duocarmycin TM (a potent antitumor antibiotic), linked via MA-PEG4-vc-PAB-DMEA. | Inquiry | |
| BADC-00744 | MC-vc-PAB-(PEG2)-duocarmycin TM | |
| MC-vc-PAB-(PEG2)-duocarmycin TM is a drug-linker conjugate for ADC by using Duocarmycin TM (a potent antitumor antibiotic), linked via MA-MC-vc-PAB-(PEG2). | Inquiry | |
| BADC-00746 | MC-vc-PAB-(PEG2)-duocarmycin DM | |
| MC-vc-PAB-(PEG2)-duocarmycin DM is a drug-linker conjugate for ADC by using Duocarmycin DM (a potent antitumor antibiotic), linked via MA-MC-vc-PAB-(PEG2). | Inquiry |
